Clinical Trial Update: Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

Completed regulatory post-marketing commitment trial of voriconazole for Scedosporiosis; results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scedosporiosis

Drugs mentioned

• VFEND (Voriconazole)

Snippet

Sponsor: Pfizer | Conditions: Scedosporium Infection | Status: COMPLETED | Results posted: 2013-12-17